Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women

International Journal of Infectious Diseases

Volumn 7, Issue 2, 2003, Pages 132-137

  Sanchez Palacios, C ^a   Gotuzzo, E ^b   Vandamme, A M ^c   Maldonado, Y ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; EDUCATION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LEUKEMIA; MAJOR CLINICAL STUDY; PERU; POLYMERASE CHAIN REACTION; PREGNANCY; RANDOMIZATION; RISK FACTOR; SCABIES; SEROPREVALENCE; SEXUAL INTERCOURSE; VIRUS INFECTION; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 0038000661     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90009-9     Document Type: Article

References (69)

1. Gessain A, Barin F, Vernant J, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-412.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-2035.
3. Meytes D, Schochat B, Lee H, et al. Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet 1990; 336:1533-1535.
4. Kazura JW, Saxinger WC, Wenger J, et al. Epidemiology of human T cell leukemia virus type I infection in East Sepik Province, Papua New Guinea. J Infect Dis 1987; 155:1100-1107.
5. Yanagihara R, Ajdukiewicz AB, Garruto RM, et al. Human T-lymphotrophic virus type I infection in the Solomon islands. Am J Trop Med Hyg 1991; 44:122-130.
6. Tajima K. Worldwide distribution of HTLV. Jpn J Cancer Res 1998; 89:inside front cover.
7. Maloney EM, Murphy EL, Figueroa JP, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica: geographic and ecologic determinants. Am J Epidemiol 1991; 133:1125-1134.
8. Maeda Y, Furukawa M, Takehara Y, et al. Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int J Cancer 1984; 33:717-720.
9. Lee HH, Swanson P, Rosenblatt JD, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; 337:1435-1439.
10. Williams AE, Fang CT, Slamon DJ, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in US blood donors. Science 1988; 240:643-646.
11. de The G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 1993; 5:381-386.
12. Jason JM, McDougal JS, Cabradilla C, Kalyanaraman VS, Evatt BL. Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients. Am J Hematol 1985; 20:129-137.
13. Hirata M, Hayashi J, Noguchi A, et al. The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission. Int J Epidemiol 1992; 2:989-994.
14. Nyambi P, Ville Y, Louwagie J, et al. Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. A prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:187-192.
15. Hino S, Katamine S, Miyata H, Tsuji Y, Yamabe T, Miyamoto T. Primary prevention of HTLV-I in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S199-S203.
16. Kinoshita K, Amagasaki T, Hino S, et al. Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res 1987; 78:674-680.
17. Takahashi K, Takezaki T, Oki T, et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotrophic virus type 1. The Mother-to-Child Transmission Study Group. Int J Cancer 1991; 49:673-677.
18. Satow Y, Hashido M, Ishikawa K, et al. Detection of HTLV-I antigen in peripheral and cord blood lymphocytes from carrier mothers. Lancet 1991; 338:915-916.
19. Fujino T, Fujiyoshi T, Yashiki S, Sonoda S, Otsuka H, Nagata Y. HTLV-I transmission from mother to fetus via placenta. Lancet 1992; 340:1157.
20. Kawase K, Katamine S, Moriuchi R, et al. Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals. Jpn J Cancer Res 1992; 83:968-977.
21. Katamine S, Moriuchi R, Yamamoto T, et al. HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet 1994; 343:1326-1327.
22. Saito S, Furuki K, Ando Y. et al. Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction. Jpn J Cancer Res 1990; 81:890-895.
23. Zamora T, Zaninovic V, Kajiwara M, Komoda H, Hayami M, Tajima K. Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia. Jpn J Cancer Res 1990; 81:715-719.
24. de Rivera IL, Amador L, Mourra S, Li Z, Rasheed S. Geographical clustering of human T-cell lymphotropic virus type 1 infection in Honduras. J Clin Microbiol 1995; 33:2999-3003.
25. Gotuzzo E, De las Casas C, Deza L, Cabrera J, Castaneda C, Watts D. Tropical spastic paraparesis and HTLV-I infection: clinical and epidemiological study in Lima, Peru. J Neurol Sci 1996; 143:114-117.
26. Miller GJ, Lewis, LL, Colman SM, et al. Clustering of human T lymphotropic virus type I seropositive in Montserrat, West Indies: evidence for an environmental factor in transmission of the virus. J Infect Dis 1994; 170: 44-50.
27. Gessain A, Mahieux R, de The G. Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S132-S145.
28. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993; 167:57-65.
29. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S2-S7.
30. Gotuzzo E, Sanchez J, Escamilla J, et al. Human T cell lymphotropic virus type I infection among female sex workers in Peru J Infect Dis 1994; 169:754-759.
31. Kramer A, Maloney EM, Morgan OS, et al. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol 1995; 142:1212-1220.
32. Gotuzzo E, Escamilla J, Phillips IA, Sanchez J, Wignall FS, Antigoni J. The impact of human T-lymphotrophic virus type I/II infection on the prognosis of sexually acquired cases of acquired immunodeficiency syndrome. Arch Intern Med 1992; 152:1429-1432.
33. Zabaleta M, Peralta J, Birges J, Bianco N, Echevarria de Perez G. HTLV-I associated myelopathy in Venezuela. J AIDS 1994; 7:1289-1290.
34. Merino F, Robert-Guroff M, Clark J, Biondo-Bracho M, Blattner WA, Gallo RC. Natural antibodies to human T-cell leukemia/lymphoma virus in healthy Venezuelan populations. Int J Cancer 1984; 34:501-506.
35. Vasquez P, Sanchez G, Volante C, et al. Human T-lymphotrophic virus type I: new risk for Chilean population. Blood 1991; 78:850-851.
36. Inostroza J, Diaz P, Saunier C. Prevalence of antibodies to HTLV-I in South American Indians (Mapuches) from Chile. Scand J Infect Dis 1991; 23:507-508.
37. Nogueira CM, Cavalcanti M, Schechter M, Ferreira OC Jr. Human T lymphotrophic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brazil. Vox Sang 1996; 70:47-48.
38. Galvao-Castro B, Loures L, Rodrigues LG, et al. Distribution of human T-lymphotrophic virus type I among blood donors: a nationwide Brazilian study. Transfusion 1997; 37:242-243.
39. Maloney EM, Ramirez H, Levin A, Blattner WA. A survey of the human T-cell lymphotrophic virus type I (HTLV-I) in south-western Colombia. Int J Cancer 1989; 44:419-423.
40. Zurita S, Costa C, Watts D, et al. Prevalence of human retroviral infection in Quillabamba and Cuzco, Peru: a new endemic area for human T cell lymphotrophic virus type I. Am J Trop Med Hyg 1997; 56:561-565.
41. Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I/II and associated diseases. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S119-S123.
42. Fujiyoshi T, Yashiki S, Fujiyama C, et al. Ethnic segregation of HTLV-I and HTLV-II carriers among South American native Indians. Int J Cancer 1995; 63:510-515.
43. Fujiyoshi T, Li HC, Lou H, et al. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999; 15:1235-1239.
44. Gessain A, Gallo R, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992; 66:2288-2295.
45. Yamashita M, Ido E, Miura T, Hayami M. Molecular epidemiology of HTLV-I in the world. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S124-S131.
46. Miura T, Fukunaga T, Igarashi T, et al. Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc Natl Acad Sci USA 1994; 91:1124-1127.
47. Yamashita M, Picchio G, Veronesi R, Ohkura S, Bare P, Hayami M. HTLV-Is in Argentina are phylogenetically similar to those of other South American countries, but different from HTLV-Is in Africa. J Med Virol 1998; 55: 152-160.
48. Gallo RC. The first human retrovirus. Sci Am 1986; 255:88-98.
49. Vandamme AM, Liu HF. Goubau P, Desmyter J. Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I. Virology 1994; 202:212-223.
50. Van Doreen S, Gotuzzo E, Salemi M, et al. Evidence for a post-Columbian introduction of human T-cell lymphotropic virus (type I) in Latin America. J Gen Virol 1998; 79:2695-2708.
51. Gotuzzo E, Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999; 60:146-149.
52. Taylor GP. The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S8-S11.
53. Vrielink H, Zaaijer H, Reesink H. The clinical relevance of HTLV type I and II in transfusion medicine. Transfus Med Rev 1997; 11:173-179.
54. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-1 infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322:383-388.
55. Anderson DW, Epstein JS, Lairmore MD, et al. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors. Blood 1989; 74:2585-2591.
56. Kaplan JE, Khabbaz RF, Murphy EL, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:193-201.
57. Murphy EL, Wilks R, Hanchard B, et al. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int J Epidemiol 1996; 25:1083-1089.
58. Lazzarin A, Saracco A, Musicco M, Nocolosi A. Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med 1991; 151:2411-2416.
59. Seydel J, Kramer A. Transmission and population dynamics of HTLV-I infection. Int J Cancer 1996; 66:197-200.
60. Hayashi J, Kishihara Y, Yoshimura E, et al. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg 1997; 56:71-75.
61. Tachibana N, Okayama A, Ishizaki J, et al. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer 1988; 42:829-833.
62. Marsh BJ. Infectious complications of human T cell leukemia/lymphomavirus type I infection. Clin Infect Dis 1996; 23:138-145.
63. Mollison LC, Lo ST, Marning G. HTLV-I and scabies in Australian aborigines. Lancet 1993; 341:1281-1282.
64. Cordoliani F, Vasseur E, Baccard M, et al. Ivermectin-responsive crusted scabies in HTLV1 carrier. Dermatology 1996; 192:351-352.
65. Daisley H, Charles W, Suite M. Crusted (Norwegian) scabies as a pre-diagnostic indicator for HTLV-1 infection. Trans R Soc Trop Med Hyg 1993; 87:295.
66. Egawa K, Johno M, Hayashibara T, Ono T. Familial occurrence of crusted (Norwegian) scabies with adult T-cell leukaemia. Br J Dermatol 1992; 127:57-59.
67. Suzumiya J, Sumiyoshi A, Kuroki Y, Inoue S. Crusted (Norwegian) scabies with adult T-cell leukemia. Arch Dermatol 1985; 121:903-904.
68. Del Giudice P, Sainte Marie D, Gerard Y, Couppie P, Pradinaud R. Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotrophic virus type I-seropositive patients? J Infect Dis 1997; 176:1090-1092.
69. Takezaki T, Tajima K, Ito M, et al. Short-term breastfeeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia 1997; 11(suppl 3):60-62.